Industry, government, and academic panel discussion on multiple comparisons in a “real” phase three clinical trial

Peter Bauer; George Chi; Nancy Geller; A Lawrence Gould; David Jordan; Surya Mohanty; Robert O’Neill; Peter Westfall

Industry, government, and academic panel discussion on multiple comparisons in a “real” phase three clinical trial

Peter Bauer, George Chi, Nancy Geller, A Lawrence Gould, David Jordan, Surya Mohanty, Robert O’Neill, Peter Westfall

Business Administration

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	691–701
Journal	Journal of Biopharmaceutical Statistics
State	Published - 2003

Cite this

@article{a82a7a63de514831bd8522154943a585,

title = "Industry, government, and academic panel discussion on multiple comparisons in a “real” phase three clinical trial",

author = "Peter Bauer and George Chi and Nancy Geller and Gould, {A Lawrence} and David Jordan and Surya Mohanty and Robert O{\textquoteright}Neill and Peter Westfall",

year = "2003",

language = "English",

pages = "691–701",

journal = "Journal of Biopharmaceutical Statistics",

}

TY - JOUR

T1 - Industry, government, and academic panel discussion on multiple comparisons in a “real” phase three clinical trial

AU - Bauer, Peter

AU - Chi, George

AU - Geller, Nancy

AU - Gould, A Lawrence

AU - Jordan, David

AU - Mohanty, Surya

AU - O’Neill, Robert

AU - Westfall, Peter

PY - 2003

Y1 - 2003

M3 - Article

SP - 691

EP - 701

JO - Journal of Biopharmaceutical Statistics

JF - Journal of Biopharmaceutical Statistics

ER -

Industry, government, and academic panel discussion on multiple comparisons in a “real” phase three clinical trial

Fingerprint

Cite this